AEGON N.V. 1999 Annual Report (Form 20-F) Summary
Business Context and Reporting Period
This filing covers the fiscal year ended December 31, 1999, for AEGON N.V., an international insurer headquartered in The Hague, The Netherlands. The Group operates primarily in the Netherlands, the USA, the United Kingdom, Hungary, and Spain, with a core focus on life insurance, pensions, and related savings products (approx. 90% of business). The 1999 reporting period was defined by significant strategic expansion through major acquisitions.
Key Financial Metrics (Dutch Accounting Principles)
| Metric | 1999 (EUR Millions) | 1998 (EUR Millions) | Change |
|---|---|---|---|
| Total Revenues | 22,374 | 17,179 | +30% |
| Premium Income | 14,980 | 11,550 | +30% |
| Investment Income | 6,690 | 5,003 | +34% |
| Income Before Tax | 2,181 | 1,634 | +33% |
| Net Income | 1,570 | 1,247 | +26% |
| Net Income Per Share | 2.56 | 2.16 | +19% |
| Total Assets | 228,808 | 131,196 | +74% |
| Shareholders' Equity | 13,543 | 7,934 | +71% |
Note: US GAAP Net Income for 1999 was EUR 1,601 million.
Material Changes vs. Prior Period
- Acquisitions: The primary driver of growth was the July 21, 1999, acquisition of Transamerica Corporation (USA) for approximately EUR 10.2 billion (cash and stock). This made AEGON one of the largest life insurers in the US. Additionally, the Group acquired the UK life operations of Guardian Royal Exchange in October 1999 and Covadonga S.A. (Spain) in December 1999.
- Revenue Growth: Total revenues rose 30% (9% autonomous growth). Life insurance premiums grew 36% to EUR 12.8 billion, largely due to Transamerica and Guardian.
- Profitability: Net income increased 26% to EUR 1.57 billion. Autonomous growth (excluding acquisitions and currency) was 11%.
- Balance Sheet Expansion: Total assets increased significantly due to the consolidation of acquired entities. Shareholders' equity grew to EUR 13.5 billion, driven by new share issuances to fund acquisitions and retained earnings.
- Divestitures: The Group sold the Providian property and casualty business in April 1999 and deconsolidated the non-core banking unit Labouchere in anticipation of its sale.
Guidance, Outlook, and Risks
- Strategy: AEGON maintains a target of at least 10% annual earnings per share growth and a minimum return on investment of 12% for new business. The strategy emphasizes a decentralized structure and selective acquisitions in existing markets.
- Subsequent Events: In early 2000, AEGON announced plans to sell the majority of Transamerica's non-insurance operations (finance, leasing, real estate) and entered negotiations to sell Labouchere to Dexia for approx. EUR 900 million.
- Risks:
- Market Risk: Exposure to interest rate changes, currency fluctuations (USD/GBP vs. EUR), and equity market volatility. A 15% decrease in non-euro currencies could negatively impact net income by ~9%.
- Regulatory: Subject to strict supervision in the US (NAIC Risk-Based Capital), UK (DTI), and Netherlands (Verzekeringskamer). The Gramm-Leach-Bliley Act in the US impacts privacy and competition.
- Operational: Integration risks associated with the Transamerica and Guardian acquisitions. Spain's motor insurance segment remains unprofitable due to price competition.
Investor Verification Checklist
- Acquisition Integration: Verify the progress of integrating Transamerica and Guardian Royal Exchange, specifically regarding cost synergies and retention of key personnel.
- Non-Core Divestitures: Monitor the timeline and valuation for the sale of Transamerica's non-insurance operations and Labouchere to ensure they meet strategic disposal goals.
- Spain Motor Segment: Review the turnaround plan for the Spanish motor insurance business, which contributed to a net loss in that region.
- Capital Structure: Assess the impact of the increased debt load (approx. EUR 1.1 billion assumed from Transamerica) on the Group's leverage ratios and credit ratings.
- Accounting Differences: Note the significant differences between Dutch Accounting Principles (DAP) and US GAAP, particularly regarding the treatment of goodwill (charged to equity under DAP) and realized gains on investments.